The OECD holds a roundtable on competition issues in the distribution of pharmaceuticals

Executive summary, by the Secretariat * From the discussion at the roundtable, the delegates’ submissions and the invited presentations and papers, the following points have emerged: (1) Regulatory needs and competition concerns in the market for the distribution of pharmaceuticals are shaped by the distinctive economic features of the pharmaceuticals sector, which are not shared by other industries. Policy-makers and enforcers need to understand these factors thoroughly to be able to intervene in this sector. The market for prescription pharmaceuticals has characteristics that render it very different from other markets in which consumer goods are sold. Supply is characterised by a considerable degree of market power, due to the presence of patents designed to reward the high

L'accès à cet article est réservé aux abonnés

Déjà abonné ? Identifiez-vous

L’accès à cet article est réservé aux abonnés.

Lire gratuitement un article

Vous pouvez lire cet article gratuitement en vous inscrivant.

 

Version PDF

Auteur

  • OECD - Competition Division (Paris)

Citation

OECD, The OECD holds a roundtable on competition issues in the distribution of pharmaceuticals, 27 février 2014, e-Competitions February 2014, Art. N° 85582

Visites 78

Tous les numéros

  • Latest News issue 
  • Tous les News issues
  • Latest Special issue 
  • Tous les Special issues